This collection of works brings together experts in the field of human retroviral pathogenesis, vaccine development, and the clinical treatment of AIDS. One of the greatest problems facing the development of an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelope glycoprotein, to undergo amino acid hypervariability, thus making a vaccine against one envelope glycoprotein ineffective against other viruses due to their mutability.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Preface; K. Ugen. The Two Principal Viremias and HIV: A Comparison of Viral and Host Characteristics; C.L. Bristow. Potential Role of Human T Cell Leukemia/Lymphoma Viruses (HTLV) in Diseases other than Acute T Cell Leukemia/Lymphoma (ATL); T.C. Gentile, T.P. Loughran. Viral-Related Proteins in Immune Dysfunction Associated with Aids; G.J. Cianciolo. Carbohydrate Interactions and HIV-1; T. Kieber-Emmons. HTLV-I and II Infection - Immunological and Molecular Aspects; M.K. Bennet, M.G. Agadjanyan. Vaccine Approaches for Human T-Cell Lymphotropic Virus Type I; G. Dekaban, et al. Immune Responses Against HIV-2; E. Björling. Human Retroviral Infection: Immunological and Molecular Therapies; H.F. Staats, J.R. McGhee. Nucleic Acid Vaccination Against HIV-1; A. Shah, et al. Passive Immunotherapy against HIV-1: Current Status and Potential; J.P. Cotropia, K.E. Ugen. Human Immunodeficiency Virus Type 1 (HIV-1) Accessory Genes: Targets for Therapy; S. Kudchodkar, et al. A New Generation of Anti-Viral Therapeutics designed to prevent the Use of Chemokine Receptors for Entry by HIV-1; B.J. Doranz, R.W. Doms. Protease Inhibitors and HIV-1 Genetic Variability in Infected Children; M.M. Goodenow, et al. Gene Therapy and HIV-1 Infection: Experimental Approaches, Shortcomings and Possible Solutions; R. Dornburg, R. Pomerantz. List of Contributors.
Book by None
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Book Booth, Berea, OH, U.S.A.
Hard Cover. Condizione: New. New condition. 368 pages. Codice articolo S59-022118
Quantità: 1 disponibili
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Codice articolo ABEOCT25-70468
Quantità: 1 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In. Codice articolo ria9780306462221_new
Quantità: Più di 20 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 659503-n
Quantità: 15 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition. Codice articolo 659503
Quantità: 15 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 392. Codice articolo 263100357
Quantità: 4 disponibili
Da: moluna, Greven, Germania
Condizione: New. The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leuke. Codice articolo 65992553
Quantità: Più di 20 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. Print on Demand pp. 392 Illus. Codice articolo 5828890
Quantità: 4 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. PRINT ON DEMAND pp. 392. Codice articolo 183100367
Quantità: 4 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Buch. Condizione: Neu. Neuware - The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established 'cure' for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability. Codice articolo 9780306462221
Quantità: 2 disponibili